Willow Biosciences To Raise $20.0 Million In Bought Deal Financing

Willow Biosciences (TSX: WLLW) this evening announced that it will be conducting a bought deal financing. Lead by Eight Capital and BMO Capital Markets, the company will look to raise gross proceeds of $20.0 million.

A total of 12.1 million common shares are to be offered under the financing, with no warrant attached to the offering. Shares will be sold at a price of $1.65 per each, for total gross proceeds of $20.0 million. A 15% over-allotment option has also been granted in connection with the financing.

Net proceeds from the financing are to be used to assist in accessing new markets for the firms cannabinoid portfolio, as well as to expedite the commercialization of new cannabinoids and access additional manufacturing capacity. Funds will also be used for working capital and general corporate purposes.

Willow Biosciences last traded at $1.91 on the TSX.


FULL DISCLOSURE: Willow Biosciences Inc is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Willow Biosciences Inc on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Leave a Reply

Video Articles

First Majestic Silver: The Santo Nino Discovery

Avino Silver Q1 Earnings: The Record Streak Continues!

Aya Gold & Silver Q1 Earnings: From Kitchen Sink to Record Results

Recommended

Emerita Resources Intends To Appeal Exploitation License Granted To Minera Los Frailes

First Majestic Silver: The Santo Nino Discovery

Related News

The Future Of Cannabinoid Manufacturing? – The Daily Dive feat Trevor Peters of Willow Biosciences

Joining us for the first time on The Daily Dive today is that of Trevor...

Thursday, January 7, 2021, 12:30:00 PM

Willow Biosciences Completes Warrant Acceleration, Boasts $48.4 Million Cash Position

Willow Biosciences (TSX: WLLW) this morning provided an update on its acceleration of outstanding common...

Wednesday, March 3, 2021, 07:40:32 AM

Willow Biosciences Announces First Commercial Production Of CBG To Occur In Q1 2021

Willow Biosciences (TSX: WLLW) announced major news this morning in that it has advanced its...

Wednesday, December 16, 2020, 08:03:32 AM

Willow Biosciences Increases Bought Deal Financing To $25.0 Million

Late last night, Willow Biosciences (TSX: WLLW) announced the upsizing of its bought deal financing...

Friday, February 12, 2021, 07:25:43 AM

Willow Biosciences Enters Multi Year CBG Supply Deal

Willow Biosciences (TSX: WLLW) this morning announced its first multi-year supply agreement. The company is...

Thursday, June 10, 2021, 07:46:54 AM